Middlemen are negotiating contracts deals where pharmacists can't tell the patients that paying cash might actually be less expensive than the insurance co-payment. The middlemen then pocket the difference. Elsewhere on Capitol Hill, Republicans are signalling support for changes to the 340B drug discount program.
from Kaiser Health News http://ift.tt/2DwpNrv
Rose
0 comments:
Post a Comment